December 17, 2017 | Four new, joint medical research projects by Israeli and British scientists focused on stem cells were awarded a funding boost of roughly $2 million by the Britain Israel Research and Academic Exchange program (BIRAX), a British Council initiative founded in 2011, in partnership with the British Embassy in Israel, the Pears Program for Global Innovation, which bridges between Israeli tech and the developing world, and the UK-Jewish charity UJIA. The new round of funding will go toward projects examining stem cell therapies for diabetes, heart disease, leukemia, anemia and Alzheimer’s disease, and will bring together scientists from the University of Edinburgh, the Weizmann Institute for Science, the Technion–Israel Institute for Technology, the Hebrew University of Jerusalem, Exeter University, the University of Cambridge and the University of Glasgow, the UK’s Jewish Chronicle reported.
Facebook comments